As BCR::ABL1pos and NEG ALL genetic subgroups may constitute up to 70% of adult ALL, it was important for us to find relatively easily accessible prognostic markers like CNA for more relevant therapeutic decisions. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.